Juventa Regenerative Medicine
The Rheumatoid arthritis treatment cost in Mexico typically starts with an extended analysis of blood, which runs $100 to $100, and may involve inpatient diagnosis for rheumatological disease costing $600 to $700. Specialized therapies like curcumin IV therapy range from $300 to $600. Total expenses depend on disease severity and medication protocols, offering 50–70% savings compared to the US. Top destinations for care include Tijuana, Playa del Carmen, and Monterrey.
Typical Rheumatoid Arthritis Treatment Costs in Mexico
Bookimed Expert Insight: Patients seeking established regenerative protocols should consider centers with CSG accreditation. Immunotherapy Regenerative Medicine in Puerto Vallarta offers 20 years of experience with multidisciplinary teams. For those prioritizing high hygiene and service standards, Monterrey provides Joint Commission International (JCI) accredited facilities like Hospital San José. These specialized clinics are best for international patients from cases requiring advanced biological or mesenchymal cell therapies.
| Mexico | Turkey | Austria | |
| Curcumin IV Therapy | from $250 | from $350 | from $350 |
No hidden fees – just official clinic prices. Pay at the clinic for Rheumatoid arthritis treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Rheumatoid arthritis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Rheumatoid arthritis treatment journey.
Dr. Luis Padilla is a physician who specializes in gynecologic oncology, general practice, and healthcare administration. He helped introduce the da Vinci Robotic Assisted Surgical System, which improved minimally invasive surgery.
Dr. Padilla has worked as Associate Administrator for Health Workforce at HRSA. He also served as Director of the NHSC. In these roles, he influenced national health policy and workforce training. He has received the People’s Choice Award and the People Living Through Cancer Award for his commitment to patient care.
He served on the National Advisory Council of the NHSC from 2007 to 2010. He earned degrees from UC Irvine, Wake Forest, Brown, Northwestern, and the University of Minnesota.